These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 363642)

  • 21. Double blind cross-over clinical trial of acebutolol and propranolol in angina pectoris.
    Pandhi P; Sethi V; Sharma BK; Wahi PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):598-600. PubMed ID: 3908331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM; Rabot D; Herrero G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of acebutolol in angina pectoris with ergometric evaluation].
    Beugin JP; Caux G; Gamblin J; Bisch JF; Cornaert P; Dutoit A; Croccel L
    LARC Med; 1982 May; 2(5):456-8. PubMed ID: 7167022
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
    Rousseau MF; Pouleur H; Cocco G; Wolff AA
    Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Favorable effects of acebutolol on exercise performance and angina in men with coronary artery disease.
    Steele P; Gold F
    Chest; 1982 Jul; 82(1):40-3. PubMed ID: 7044708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo controlled crossover study.
    Cherchi A; Lai C; Angelino F; Trucco G; Caponnetto S; Mereto PE; Rosolen G; Manzoli U; Schiavoni G; Reale A
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):569-72. PubMed ID: 3905631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of the administration of acebutolol in patients with chronic angina of effort].
    Uslenghi E; Donegani E; Forni B; Baroni F; Zardini P
    G Ital Cardiol; 1981; 11(7):973-8. PubMed ID: 7308653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of exercise tolerance of cardiac patients by bicycle, treadmill and treadmill plus isometric exercise with and without nifedipine.
    Vuori I; Hämäläinen H; Pietilä J; Kallio V
    Ann Clin Res; 1987; 19(5):328-33. PubMed ID: 3442398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ergometric surveillance of acebutolol treatment in chronic angina].
    Wazana M; Rey G; Sacrez A
    Ann Cardiol Angeiol (Paris); 1978; 27(4):325-31. PubMed ID: 686638
    [No Abstract]   [Full Text] [Related]  

  • 30. Low-dose acebutolol given once daily in the treatment of chronic angina pectoris.
    Piña IL; Smith EV; Weidler DJ
    J Clin Pharmacol; 1988 May; 28(5):427-30. PubMed ID: 3392240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acebutolol and left ventricular function: assessment by radionuclide angiography.
    Katz RJ; DiBianco R; Singh S; Bortz R; Bates HR; Sauerbrunn B; Laddu AR; Fletcher RD
    Clin Pharmacol Ther; 1981 Feb; 29(2):149-54. PubMed ID: 7460480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of left ventricular myocardial perfusion and cavity size to beta-blockade by acebutolol.
    Frick MH; Valle M; Korhola O; Hekali P; Riihimäki E
    Ann Clin Res; 1978 Apr; 10(2):66-70. PubMed ID: 28072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acebultolol: basis for the prediction of effect on exercise tolerance.
    Biron P; Tremblay G
    Clin Pharmacol Ther; 1976 Mar; 19(3):333-8. PubMed ID: 4256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of the antihypertensive action of acebutolol at rest and during exercise. Apropos of 20 cases].
    Barraine R; Bonot G
    Ann Cardiol Angeiol (Paris); 1977; 26(4):339-43. PubMed ID: 329738
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of acebutolol on chronic stable angina pectoris. A placebo-controlled, double-blind, randomized crossover study.
    DiBianco R; Singh S; Singh JB; Katz RJ; Bortz R; Gottdiener JS; Spodick DH; Laddu AR; Fletcher RD
    Circulation; 1980 Dec; 62(6):1179-87. PubMed ID: 6777070
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of acebutolol in angina pectoris].
    Rey G; Wazana M; Sacrez A
    Cardiology; 1978; 63 Suppl 1():32-6. PubMed ID: 688290
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acebutolol in coronary heart disease: an ergometric double-blind study (author's transl)].
    Böhm H; Ludwig B
    Dtsch Med Wochenschr; 1980 Jul; 105(27):958-60. PubMed ID: 7408684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acebutol (Sectral) in angina pectoris treatment.
    Fiserová J; Hlavácek K; Vávra M; Holík F; Münz J
    Acta Univ Carol Med (Praha); 1979; 25(5-6):335-42. PubMed ID: 262361
    [No Abstract]   [Full Text] [Related]  

  • 39. Acebutolol: a review of its pharmacology, pharmacokinetics, clinical uses, and adverse effects.
    Singh BN; Thoden WR; Wahl J
    Pharmacotherapy; 1986; 6(2):45-63. PubMed ID: 3012486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effects of oral acebutolol and propranolol at rest and during exercise in ischemic heart disease: double-blind placebo crossover study utilizing radionuclide ventriculography.
    Kaul S; Hecht HS; Seidman R; Hopkins J; Singh BN
    Am Heart J; 1984 Sep; 108(3 Pt 1):469-74. PubMed ID: 6382987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.